Equities

Salus Ljubljana dd

0HMV:LSE

Salus Ljubljana dd

Actions
  • Price (EUR)0.00
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Dec 30 1899.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Salus Ljubljana dd is a Slovenia-based company engaged in the wholesale and distribution of medical products. The Company’s portfolio includes pharmaceuticals, medical devices, medical supplies, food supplements, cosmetic products and other health products. The Company's core clients are pharmacies, hospitals and health centers from both Slovenia and abroad. Moreover, Salus Ljubljana dd offers the products to its business partners through the Internet store. The Company also provides additional services related to the registration of medicines and the distribution and storage of pharmaceuticals and other medical products.

  • Revenue in EUR (TTM)623.43m
  • Net income in EUR11.51m
  • Incorporated1974
  • Employees144.00
  • Location
    Salus Ljubljana ddLitostrojska cesta 46 ALJUBLJANA 1000SloveniaSVN
  • Phone+386 15899100
  • Fax+386 15681022
  • Websitehttps://www.salus.si/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
SALR:LJU since
announced
Transaction
value
Medorion dooAnnounced19 Jun 202319 Jun 2023Announced1.00%--
Data delayed at least 20 minutes, as of May 16 2024.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.